Figure 1
Distribution of mutations among patients with AML derived from a MPN. Pre-exisitng MPN diagnosis and cytogenetic risk category as defined by Slovak et al13 is listed as well.
Distribution of mutations among patients with AML derived from a MPN. Pre-exisitng MPN diagnosis and cytogenetic risk category as defined by Slovak et al13 is listed as well.
